Dr. Alan So, MD, FRCSC, Uro-Oncologist, talks about the different treatment options for prostate cancer. Canada’s win over ...

Accurate calculation of prostate-specific antigen doubling time can be crucial for prostate cancer treatment decisions but is ...

[8] These study participants may be end-stage prostatitis patients who failed treatment with the study drugs, which are commonly prescribed in the community setting. Men with less severe symptoms ...

especially in advanced stages such as castration-resistant prostate cancer, is challenging to treat. Traditional therapies targeting ... Study Finds New Blood Test Predicts Prognosis for Advanced ...

Combining an existing small-molecule protein therapy called tumor necrosis factor related apoptosis-inducing ligand (TRAIL) ...

A major discovery by Australian researchers of a key driver of prostate cancer could lead to the next generation of targeted treatments with fewer “awful” side effects.

A new study gives hope for improved treatment of prostate cancer, the second most diagnosed cancer among men worldwide.

According to ZERO Prostate Cancer, Novartis has committed $7.5 million to the initiative.

Combining an existing small-molecule protein therapy called tumor necrosis factor related apoptosis-inducing ligand with ...

from the special challenges of trying to treat our oldest patients—those who were over 75 who were in this population with metastatic hormone-sensitive prostate cancer? Dorff: It’s challenging ...